Matches in Wikidata for { <http://www.wikidata.org/entity/Q69951786> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q69951786 description "artículu científicu espublizáu en setiembre de 1971" @default.
- Q69951786 description "im September 1971 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69951786 description "scientific article published on 01 September 1971" @default.
- Q69951786 description "wetenschappelijk artikel" @default.
- Q69951786 description "наукова стаття, опублікована у вересні 1971" @default.
- Q69951786 name "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 name "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 type Item @default.
- Q69951786 label "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 label "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 prefLabel "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 prefLabel "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 P1433 Q69951786-56CDA895-B334-4B8D-9DB0-64B292EFEC2A @default.
- Q69951786 P1476 Q69951786-A7338CF9-735A-4522-A0B8-7BEF8F589E74 @default.
- Q69951786 P2093 Q69951786-492ADF72-13A8-4D9E-A5E7-B2446C757C4C @default.
- Q69951786 P2093 Q69951786-CD57A2FA-2646-4CE8-A574-81027F1413DC @default.
- Q69951786 P304 Q69951786-302C0678-8340-4D0A-AF55-C16370508CDA @default.
- Q69951786 P31 Q69951786-078ED6EC-DAD1-44AF-AE73-AC6C680EFC47 @default.
- Q69951786 P356 Q69951786-0E186A93-3B56-48F7-B0CF-537BA5D69A0E @default.
- Q69951786 P433 Q69951786-C806592E-4FBC-4370-819E-C4DF849EBDF4 @default.
- Q69951786 P478 Q69951786-687BDD87-6FA5-43A3-B3D5-00E0DAEFA22F @default.
- Q69951786 P577 Q69951786-85046BD4-70F7-489E-9912-36BA7F0364EE @default.
- Q69951786 P698 Q69951786-11088F56-AF04-4EB9-9B4F-474C7017AB5E @default.
- Q69951786 P921 Q69951786-5F4A1715-5FE5-4721-8280-53209FADB54F @default.
- Q69951786 P921 Q69951786-B98F4B5E-B269-47D8-A236-408E51C9B2E2 @default.
- Q69951786 P921 Q69951786-EC9BAD16-6F2D-4684-A3A7-E1D862B1317A @default.
- Q69951786 P356 J.0954-6820.1971.TB07423.X @default.
- Q69951786 P698 4941227 @default.
- Q69951786 P1433 Q10400528 @default.
- Q69951786 P1476 "The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure" @default.
- Q69951786 P2093 "B Sigurd" @default.
- Q69951786 P2093 "K H Olesen" @default.
- Q69951786 P304 "233-240" @default.
- Q69951786 P31 Q13442814 @default.
- Q69951786 P356 "10.1111/J.0954-6820.1971.TB07423.X" @default.
- Q69951786 P433 "3" @default.
- Q69951786 P478 "190" @default.
- Q69951786 P577 "1971-09-01T00:00:00Z" @default.
- Q69951786 P698 "4941227" @default.
- Q69951786 P921 Q181754 @default.
- Q69951786 P921 Q19000661 @default.
- Q69951786 P921 Q388801 @default.